|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||0.02|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Molecular Partners ( VTX:MOLN ) Full Year 2022 Results Key Financial Results Revenue: CHF189.6m (up by CHF179.8m from...
A look at the shareholders of Molecular Partners AG ( VTX:MOLN ) can tell us which group is most powerful. With 41...
Molecular Partners (VTX:MOLN) has had a great run on the share market with its stock up by a significant 20% over the...